These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. [Clinical use of new antidepressive agents with dual action (literature review)]. De León OA Rev Med Panama; 2000; 25():24-9. PubMed ID: 15881744 [TBL] [Abstract][Full Text] [Related]
27. Monoamines, depression and antidepressant drugs. Checkley S Pharmacopsychiatry; 1988 Jan; 21(1):6-8. PubMed ID: 3283784 [TBL] [Abstract][Full Text] [Related]
28. [Drug therapy and affective disorders: state of the art]. Cugurra F Clin Ter; 1995 Oct; 146(10):577-85. PubMed ID: 8590559 [TBL] [Abstract][Full Text] [Related]
29. Designing new treatments for depression and anxiety. Chen Z; Yang J; Tobak A IDrugs; 2008 Mar; 11(3):189-97. PubMed ID: 18311656 [TBL] [Abstract][Full Text] [Related]
30. Invivo antioxidant status: a putative target of antidepressant action. Zafir A; Ara A; Banu N Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):220-8. PubMed ID: 19059298 [TBL] [Abstract][Full Text] [Related]
31. [Difficulties of animal experiments in psychopharmacology. Punctual aspects of antidepressants]. Brugger AJ; Brugger-Frigols I; Conesa P Rev Esp Fisiol; 1989; 45 Suppl():245-54. PubMed ID: 2701762 [TBL] [Abstract][Full Text] [Related]
32. Pharmacological treatment of unipolar depression. Anderson IM Curr Top Behav Neurosci; 2013; 14():263-89. PubMed ID: 22544348 [TBL] [Abstract][Full Text] [Related]
33. Desvenlafaxine succinate for major depressive disorder: a critical review of the evidence. Kamath J; Handratta V Expert Rev Neurother; 2008 Dec; 8(12):1787-97. PubMed ID: 19086875 [TBL] [Abstract][Full Text] [Related]
34. 1-(m-Chlorophenyl)piperazine induces depressogenic-like behaviour in rodents by stimulating the neuronal 5-HT(2A) receptors: proposal of a modified rodent antidepressant assay. Rajkumar R; Pandey DK; Mahesh R; Radha R Eur J Pharmacol; 2009 Apr; 608(1-3):32-41. PubMed ID: 19269287 [TBL] [Abstract][Full Text] [Related]
36. Escitalopram for the treatment of major depression and anxiety disorders. Höschl C; Svestka J Expert Rev Neurother; 2008 Apr; 8(4):537-52. PubMed ID: 18416657 [TBL] [Abstract][Full Text] [Related]
37. Pharmacogenomics in depression and antidepressants. Bondy B Dialogues Clin Neurosci; 2005; 7(3):223-30. PubMed ID: 16156381 [TBL] [Abstract][Full Text] [Related]
38. Determinants of antidepressant medication prescribing in elderly residents of aged care homes in Australia: a retrospective study. Nishtala PS; McLachlan AJ; Bell JS; Chen TF Am J Geriatr Pharmacother; 2009 Aug; 7(4):210-9. PubMed ID: 19766953 [TBL] [Abstract][Full Text] [Related]
39. [Fifty years of pharmacotherapy of mood disorders: have the expectations been fulfilled?]. Nolen WA Tijdschr Psychiatr; 2008; 50 Spec no.():111-6. PubMed ID: 19067309 [TBL] [Abstract][Full Text] [Related]
40. [Clinical and therapeutic particularities of depression in the elderly]. Maâlej M; Zouari L; Ben MS; Rakam A; Dammak M; Zouari N Tunis Med; 2008 Feb; 86(2):179-84. PubMed ID: 18444539 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]